Simulations Plus is in the application software industry and trades as part of the technology sector. The company CEO is Shawn O¿Connor. Simulations Plus Inc is a developer of drug discovery and development software for mechanistic modelling, simulation and machine learning based technologies. It also explores the application of machine learning technologies in other industries.



Previous Intraday Performance:

The SLP shares had a previous change of -0.08% which opened at 24.41 and closed at 24.50. It moved to an intraday high of 24.70 and a low of 24.26.

Business Wire:  U.S. FDA Renews DILIsym Software Licenses

Historical Performance:

Over the last five trading days, SLP shares returned 0.57% and in the past 30 trading days it returned 23.38%. Over three months, it changed 23.82%. In one year it has changed 30.51% and within that year its 52-week high was 24.70 and its 52-week low was 16.70. SLP stock is 46.71% above its 52 Week Low.

Our calculations result in a 200 day moving average of 20.11 and a 50 day moving average of 21.64. Right now, SLP stock is trading 21.81% above its 200 day moving average.

Business Wire:  U.S. FDA Renews DILIsym Software Licenses

Liquidity:

The company has a market cap of $428.8m with 17.5m shares outstanding and a float of 4.5m shares. Trading volume was 11,192 shares and has experienced an average volume of 52,076 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.

Earnings:

The last annual reported EPS for Simulations Plus was 0.49 which ended on 31st of August 2018, which according to the previous close, that is a PE of 49.96. Based on 1 analyst estimate, the estimated EPS for the next quarter is 0.11. The trailing twelve month EPS is 0.40, which comes to a trailing twelve month PE of 61.20. Historically, the PE high was 72.60 and the PE low was 25.90. If the stock reached its PE low, that would represent a price of 10.37, which is a decrease of -57.68%.

The dividend per share is currently 0.24, which is a dividend yield of 0.98%.

Base on our calculations, the intrinsic value per share is 9.86, which means it might overvalued by -148.42%

The next earnings report will be: 05-24-2019



The long-term trend of the EPS is an important number as it indicates the present value of Simulations Plus; the EPS growth rate, as it is typically called, is usually expressed as a percentage, which at this time is hard to estimate, but revenue growth has been 12.70% over the last twelve months.

Indicators Also to Watch:

Based on the latest filings, there is 56.80% of institutional ownership.

I calculated the beta to be -0.49

PR Newswire:  Sun Life Amends its Normal Course Issuer Bid to Repurchase for Cancellation up to an Additional 4 Million Common Shares

Fundamental Numbers:

Based on last reported financials, the company’s return on equity is 24.11%, return on assets is 18.07%, profit margin is 23.64%, price-to-sales is 13.59 and price-to-book is 12.58.

Company Score Card:

Results are out of six:
 4  : Growth Expectations Result
 6  : Financial Safety Result
 3  : Past Performance Result
 0  : Valuation Result
 1  : Dividend Safety Result
 2  : Overall Result

Related Tags: , , ,

Jake McWilliams
I am an independent trader, analyst and algorithmic trading expert, having worked both for the sell side (brokerage) and the buy side (fund administration). I have been trading professionally for about 20 years. I trade stocks and forex and I play both long and short positions in underlying asset or through options. I have experience with discretionary and fully automated systems (Metatrader and Quantshare).

LEAVE A REPLY

Please enter your comment!
Please enter your name here